Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer

Currently, there is no consensus about the use of adjuvant chemotherapy for patients with stage II colorectal cancer. Here, we aimed to identify and validate a prognostic mRNA expression signature for the stratification of patients with stage II colorectal cancer according to their risk for relapse....

Descripción completa

Detalles Bibliográficos
Autores principales: Rokavec, Matjaz, Özcan, Elif, Neumann, Jens, Hermeking, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467603/
https://www.ncbi.nlm.nih.gov/pubmed/37654625
http://dx.doi.org/10.1158/2767-9764.CRC-22-0489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467603/
https://www.ncbi.nlm.nih.gov/pubmed/37654625
http://dx.doi.org/10.1158/2767-9764.CRC-22-0489

Ejemplares similares